AAN 2023 Highlights Podcast Presented ByRobert van den Heuvel, Medicom ConferenceAAN 2023 14 May, 2023 19:44
Teriflunomide prevents conversion to MS in patients with RIS Presented ByDr Christine Lebrun-Frenay, Centre Hospitalier Universitaire de Nice, France TrialPhase 3, TERIS ConferenceAAN 2023 1 May, 2023 12:33
First-ever ALS platform trial reports on outcomes of 4 treatments Presented ByProf. Sabrina Paganoni, Massachusetts General Hospital, USA TrialHEALEY ALS Platform ConferenceAAN 2023 28 April, 2023 16:52
Atogepant helps prevent treatment-resistant episodic migraine Presented ByDr Patricia Pozo-Rosich, University Hospital Vall d'Hebron, Spain TrialPhase 3, ELEVATE ConferenceAAN 2023 2 May, 2023 12:12
Donanemab shows rapid and deep plaque clearance in early Alzheimer’s disease Presented ByProf. Stephen Salloway, Brown University, USA TrialTRAILBLAZER-ALZ 4 ConferenceAAN 2023 2 May, 2023 12:07
Continuous levodopa/carbidopa infusion shows favourable safety and efficacy Presented ByDr Aaron Ellenbogen , Michigan Institute for Neurological Disorders, USA TrialBeyoND ConferenceAAN 2023 2 May, 2023 12:05
EVT improves functional outcomes in Chinese patients with BAO Presented ByDr Raul Nogueira, Grady Memorial Hospital, GA, USA TrialATTENTION ConferenceAAN 2023 2 May, 2023 12:03
Allogenic T cell-based immunotherapy for the treatment of PML in development Presented ByDr George Ambalathingal, QIMR Berghofer Medical Research Institute, Australia ConferenceAAN 2023 2 May, 2023 12:01
Teriflunomide prevents conversion to MS in patients with RIS Presented ByDr Christine Lebrun-Frenay, Centre Hospitalier Universitaire de Nice, France TrialPhase 3, TERIS ConferenceAAN 2023 1 May, 2023 12:33
Stem cell therapy improves walking in more advanced progressive MS ConferenceAAN 2023 1 May, 2023 12:30
Pridopidine fails to meet the primary endpoint in Huntington’s Disease Presented ByProf. Andrew Feign, NYU Grossman School of Medicine, USA TrialPhase 3, PROOF-HD ConferenceAAN 2023 1 May, 2023 12:25
Ravulizumab effective in AQP4+ NMOSD Presented ByDr Sean Pittock, Mayo Clinic, USA TrialPhase 3, CHAMPION-NMOSD ConferenceAAN 2023 1 May, 2023 12:15
Gold nanocrystals may be effective as adjunctive MS therapy Presented ByProf. Michael Barnett, University of Sydney, Australia TrialSIONARY-MS ConferenceAAN 2023 1 May, 2023 12:12
Encouraging first results of GABAergic interneurons for focal epilepsy Presented ByDr David Spencer, Oregon Health & Science University in Portland, USA ConferenceAAN 2023 28 April, 2023 16:55
First-ever ALS platform trial reports on outcomes of 4 treatments Presented ByProf. Sabrina Paganoni, Massachusetts General Hospital, USA TrialHEALEY ALS Platform ConferenceAAN 2023 28 April, 2023 16:52
Zavegepant nasal spray exhibits good efficacy and safety in acute migraine Presented ByProf. Richard Lipton, Albert Einstein College of Medicine, USA TrialPhase 3 ConferenceAAN 2023 28 April, 2023 16:50
Original antigenic sin influences humoral immune response to SARS-CoV-2 ConferenceAAN 2023 28 April, 2023 16:47
Lecanemab may slow decline of cognition and function in AD Presented ByProf. Christopher van Dyck, Yale School of Medicine, USA TrialCLARITY AD ConferenceAAN 2023 28 April, 2023 16:44
Spinal cord stimulation eases painful diabetic neuropathy Presented ByDr Erika Petersen, University of Arkansas, USA ConferenceAAN 2023 28 April, 2023 16:41